Ocular myasthenia
Ocular Myasthenia is a subtype of Myasthenia Gravis, a neuromuscular disease that leads to fluctuating muscle weakness and fatigue. In the case of Ocular Myasthenia, the disease is limited to the muscles that control the eyes and eyelids, and symptoms are related to eyelid drooping, double vision, or both.
Symptoms[edit | edit source]
The primary symptoms of Ocular Myasthenia include ptosis (drooping of the upper eyelid) and diplopia (double vision). These symptoms may occur in one or both eyes. They may come and go over time, and they may vary in severity.
Causes[edit | edit source]
Ocular Myasthenia is caused by a breakdown in the normal communication between nerves and muscles. This breakdown is due to an autoimmune response where antibodies block, alter, or destroy the receptors for acetylcholine, a neurotransmitter that sends messages from nerve cells to muscle cells.
Diagnosis[edit | edit source]
Diagnosis of Ocular Myasthenia can be challenging due to the fluctuating nature of the symptoms. Tests that may be used in the diagnostic process include blood tests, Edrophonium test, nerve conduction studies, and imaging studies of the chest to rule out the presence of a thymoma.
Treatment[edit | edit source]
Treatment options for Ocular Myasthenia include medication, surgery, and other therapies. Medications may include cholinesterase inhibitors, which improve communication between nerves and muscles, and immunosuppressants, which reduce the production of abnormal antibodies. Surgery may be used to remove the thymus gland (thymectomy), which is often abnormal in people with myasthenia gravis. Other therapies may include plasmapheresis and intravenous immunoglobulin, which alter the immune system and provide temporary relief from symptoms.
Prognosis[edit | edit source]
The prognosis for individuals with Ocular Myasthenia varies. Some people may experience a complete remission of symptoms without treatment, while others may have a progression of symptoms to generalized myasthenia gravis. With treatment, most individuals with the condition have a normal life expectancy.
See Also[edit | edit source]
| Ocular myasthenia Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
